Bioniq's projected market share of less than 1% underscores the scale mismatch. Without comparable distribution infrastructure, brand recognition, or customer touchpoints, competing effectively against these incumbents would require capital investment far exceeding realistic projections. These competitors have spent years building loyalty programs, optimizing operations, and establishing wholesale relationships that new entrants cannot quickly replicate.